Extracellular vesicles from parasitic helminths and their potential utility as vaccines

References

• WHO/Regional Office for the Western Pacific. Food-borne trematode infections in Asia: report. Manila, Philippines: World Health Organization, Regional Office for the Western Pacific; 2004.
   Google Scholar
• Mathers C, Fat DM, Boerma JT, World Health Organization. The global burden of disease: 2004 update. Geneva: World Health Organization; 2008.
   Google Scholar
• Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006;367(9521):1521–1532.
   PubMed Web of Science ®Google Scholar
• Hotez PJ, Brindley PJ, Bethony JM, et al. Helminth infections: the great neglected tropical diseases. J Clin Investig. 2008;118(4):1311–1321.
   PubMed Web of Science ®Google Scholar
• Maizels RM, Holland MF, Falcone FH, et al. Vaccination against helminth parasites-the ultimate challenge for vaccinologists? Immunol Rev. 1999;171:125–147.
   PubMed Web of Science ®Google Scholar
• Toledo R, Bernal MD, Marcilla A. Proteomics of foodborne trematodes. J Proteomics. 2011;74(9):1485–1503.
   PubMed Web of Science ®Google Scholar
• Sotillo J, Toledo R, Mulvenna J, et al. Exploiting helminth-host interactomes through big data. Trends Parasitol. 2017;33(11):875–888.
   PubMed Web of Science ®Google Scholar
• Mulvenna J, Sripa B, Brindley PJ, et al. The secreted and surface proteomes of the adult stage of the carcinogenic human liver fluke Opisthorchis viverrini. Proteomics. 2010;10(5):1063–1078.
   PubMed Web of Science ®Google Scholar
• Sotillo J, Pearson M, Becker L, et al. A quantitative proteomic analysis of the tegumental proteins from Schistosoma mansoni schistosomula reveals novel potential therapeutic targets. Int J Parasitol. 2015;45(8):505–516.
   PubMed Web of Science ®Google Scholar
• Cancela M, Acosta D, Rinaldi G, et al. A distinctive repertoire of cathepsins is expressed by juvenile invasive Fasciola hepatica. Biochimie. 2008;90(10):1461–1475.
   PubMed Web of Science ®Google Scholar
• Crowe J, Lumb FE, Harnett MM, et al. Parasite excretory-secretory products and their effects on metabolic syndrome. Parasite Immunol. 2017;39(5):e12410-n/a.
   PubMed Web of Science ®Google Scholar
• Marcilla A, Trelis M, Cortés A, et al. Extracellular vesicles from parasitic helminths contain specific excretory/secretory proteins and are internalized in intestinal host cells. PLoS One. 2012;7(9):e45974.
   PubMed Web of Science ®Google Scholar
• Marcilla A, Martin-Jaular L, Trelis M, et al. Extracellular vesicles in parasitic diseases. J Extracell Vesicles. 2014;3:25040.
   PubMedGoogle Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373–383.
   PubMed Web of Science ®Google Scholar
• Evans-Osses I, Reichembach LH, Ramirez MI. Exosomes or microvesicles? Two kinds of extracellular vesicles with different routes to modify protozoan-host cell interaction. Parasitol Res. 2015;114(10):3567–3575.
   PubMed Web of Science ®Google Scholar
• Akers JC, Gonda D, Kim R, et al. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol. 2013;113(1):1–11.
   PubMed Web of Science ®Google Scholar
• Edgar JR. Q&A: what are exosomes, exactly? BMC Biol. 2016;14(1):46.
   PubMed Web of Science ®Google Scholar
• Yáñez-Mó M, Pia RMS, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4(Generic):1–60.
   Google Scholar
• Falker C, Hartmann A, Guett I, et al. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity. J Neurochem. 2016;137(1):88–100.
   PubMed Web of Science ®Google Scholar
• Al-Nedawi K, May L, Meehan B, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol. 2008;10(5):619–624.
   PubMed Web of Science ®Google Scholar
• Sellam J, Proulle V, Jüngel A, et al. Increased levels of circulating microparticles in primary Sjögren’s syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther. 2009;11(5):R156–R156.
   PubMed Web of Science ®Google Scholar
• Esteva-Font C, Wang X, Ars E, et al. Are sodium transporters in urinary exosomes reliable markers of tubular sodium reabsorption in hypertensive patients? Nephron Physiol. 2010;114(3):p25–p34.
   Google Scholar
• Berckmans RJ, Sturk A, Tienen VLM, et al. Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood. 2011;117(11):3172–3180.
   PubMed Web of Science ®Google Scholar
• Aline F, Bout D, Amigorena S, et al. Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. Infect Immun. 2004;72(7):4127–4137.
   PubMed Web of Science ®Google Scholar
• Coakley G, McCaskill JL, Borger JG, et al. Extracellular vesicles from a helminth parasite suppress macrophage activation and constitute an effective vaccine for protective immunity. Cell Rep. 2017;19(8):1545–1557.
   PubMed Web of Science ®Google Scholar
• Coakley G, Maizels RM, Buck AH. Exosomes and other extracellular vesicles: the new communicators in parasite infections. Trends Parasitol. 2015;31(10):477–489.
   PubMed Web of Science ®Google Scholar
• Montaner S, Galiano A, Trelis M, et al. The role of extracellular vesicles in modulating the host immune response during parasitic infections. Front Immunol. 2014;5:433.
   PubMed Web of Science ®Google Scholar
• Bernal D, Trelis M, Montaner S, et al. Surface analysis of Dicrocoelium dendriticum. The molecular characterization of exosomes reveals the presence of miRNAs. J Proteomics. 2014;105:232.
   PubMed Web of Science ®Google Scholar
• Nowacki FC, Swain MT, Klychnikov OI, et al. Protein and small non-coding RNA-enriched extracellular vesicles are released by the pathogenic blood fluke Schistosoma mansoni. J Extracell Vesicles. 2015;4(1):1–16.
   Google Scholar
• Buck AH, Coakley G, Simbari F, et al. Exosomes secreted by nematode parasites transfer small RNAs to mammalian cells and modulate innate immunity. Nat Commun. 2014;5:5488.
   PubMed Web of Science ®Google Scholar
• Zamanian M, Fraser LM, Agbedanu PN, et al. Release of small RNA-containing exosome-like vesicles from the human filarial parasite Brugia malayi: e0004069. PLoS Negl Trop Dis. 2015;9(9):e0004069.
   PubMed Web of Science ®Google Scholar
• Fromm B, Trelis M, Hackenberg M, et al. The revised microRNA complement of Fasciola hepatica reveals a plethora of overlooked microRNAs and evidence for enrichment of immuno-regulatory microRNAs in extracellular vesicles. Int J Parasitol. 2015;45(11):697–702.
   PubMed Web of Science ®Google Scholar
• Sotillo J, Pearson M, Potriquet J, et al. Extracellular vesicles secreted by Schistosoma mansoni contain protein vaccine candidates. Int J Parasitol. 2016;46(1):1–5.
   PubMed Web of Science ®Google Scholar
• Zhu L, Liu J, Dao J, et al. Molecular characterization of S. japonicum exosome-like vesicles reveals their regulatory roles in parasite-host interactions. Sci Rep. 2016;6:25885.
   PubMed Web of Science ®Google Scholar
• Zhu S, Wang S, Lin Y, et al. Release of extracellular vesicles containing small RNAs from the eggs of Schistosoma japonicum. Parasites Vectors. 2016;9(1):574.
   Web of Science ®Google Scholar
• Chaiyadet S, Sotillo J, Smout M, et al. Carcinogenic liver fluke secretes extracellular vesicles that promote cholangiocytes to adopt a tumorigenic phenotype. J Infect Dis. 2015;212(10):1636–1645.
   PubMed Web of Science ®Google Scholar
• Cwiklinski K, de la Torre-Escudero E, Trelis M, et al. The extracellular vesicles of the helminth pathogen, Fasciola hepatica: biogenesis pathways and cargo molecules involved in parasite pathogenesis. Mol Cell Proteomics. 2015;14(12):3258–3273.
   PubMed Web of Science ®Google Scholar
• Ancarola ME, Marcilla A, Herz M, et al. Cestode parasites release extracellular vesicles with microRNAs and immunodiagnostic protein cargo. Int J Parasitol. 2017;47(10–11):675–686.
   PubMed Web of Science ®Google Scholar
• Greening DW, Xu R, Ji H, et al. A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. Methods Mol Biol. 2015;1295:179–209.
   PubMedGoogle Scholar
• Livshits MA, Livshts MA, Khomyakova E, et al. Isolation of exosomes by differential centrifugation: theoretical analysis of a commonly used protocol. Sci Rep. 2015;5:17319.
   PubMed Web of Science ®Google Scholar
• Momen-Heravi F, Balaj L, Alian S, et al. Current methods for the isolation of extracellular vesicles. Biol Chem. 2013;394(10):1253.
   PubMed Web of Science ®Google Scholar
• Webber J, Clayton A. How pure are your vesicles? J Extracell Vesicles. 2013;2:1–6.
   Google Scholar
• Taylor DD, Shah S. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods. 2015;87:3–10.
   PubMed Web of Science ®Google Scholar
• Théry C, Amigorena S, Raposo G, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current Protocol Biology. 2006. Chapter 3, Unit 3.22. Wiley.
   Google Scholar
• Abels ER, Breakefield XO. Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake. Cell Mol Neurobiol. 2016;36(3):301–312.
   PubMed Web of Science ®Google Scholar
• Cheng G, Luo R, Hu C, et al. Deep sequencing-based identification of pathogen-specific microRNAs in the plasma of rabbits infected with Schistosoma japonicum. Parasitology. 2013;140(14):1751.
   PubMed Web of Science ®Google Scholar
• Hoy AM, Lundie RJ, Ivens A, et al. Parasite-derived microRNAs in host serum as novel biomarkers of helminth infection. PLoS Negl Trop Dis. 2014;8(2):e2701.
   PubMed Web of Science ®Google Scholar
• Meningher T, Lerman G, Regev-Rudzki N, et al. Schistosomal microRNAs isolated from extracellular vesicles in sera of infected patients: a new tool for diagnosis and follow-up of human schistosomiasis. J Infect Dis. 2017;215(3):378–386.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Xie N, Cui H, et al. MicroRNA let-7c regulates macrophage polarization. J Immunol. 2013;190(12):6542–6549.
   PubMed Web of Science ®Google Scholar
• Don TA, Bethony JM, Loukas A. Saposin-like proteins are expressed in the gastrodermis of Schistosoma mansoni and are immunogenic in natural infections. Int J Infect Dis. 2008;12(6):e39–e47.
   PubMed Web of Science ®Google Scholar
• Robinson MW, Corvo I, Jones PM, et al. Collagenolytic activities of the major secreted cathepsin L peptidases involved in the virulence of the helminth pathogen Fasciola hepatica. PLoS Negl Trop Dis. 2011;5(4):e1012.
   PubMed Web of Science ®Google Scholar
• Donnelly S, O’Neill SM, Sekiya M, et al. Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. Infect Immun. 2005;73(1):166–173.
   PubMed Web of Science ®Google Scholar
• Lgg P, Fonseca CT, Chiari L, et al. Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine. Immunobiology. 2006;211(1):97–104.
   PubMed Web of Science ®Google Scholar
• Han Y, Zhao B, Zhang M, et al. Biochemical properties and vaccine effect of recombinant TPx-3 from Schistosoma japonicum. Parasitol Res. 2017;116(4):1361–1372.
   PubMed Web of Science ®Google Scholar
• Figueiredo BC, Assis NRG, Morais SB, et al. Schistosome syntenin partially protects vaccinated mice against Schistosoma mansoni infection. PLoS Negl Trop Dis. 2014;8(8):e3107.
   PubMed Web of Science ®Google Scholar
• Diniz PP, Nakajima E, Miyasato PA, et al. Two SmDLC antigens as potential vaccines against schistosomiasis. Acta Trop. 2014;140:193–201.
   PubMed Web of Science ®Google Scholar
• Romeih MH, Hassan HM, Shousha TSA, et al. Immunization against Egyptian Schistosoma mansoni infection by multivalent DNA vaccine. Acta Biochim Biophys Sin (Shanghai). 2008;40(4):327–338.
   PubMed Web of Science ®Google Scholar
• Duan MM, Xu RM, Yuan CX, et al. SjHSP70, a recombinant Schistosoma japonicum heat shock protein 70, is immunostimulatory and induces protective immunity against cercarial challenge in mice. Parasitol Res. 2015;114(9):3415–3429.
   PubMed Web of Science ®Google Scholar
• Schechtman D, Tarrab‐Hazdai R, Arnon R. The 14-3-3 protein as a vaccine candidate against schistosomiasis. Parasite Immunol. 2001;23(4):213–217.
   PubMed Web of Science ®Google Scholar
• Zafra R, Pérez-Écija RA, Buffoni L, et al. Early and late peritoneal and hepatic changes in goats immunized with recombinant cathepsin L1 and infected with Fasciola hepatica. J Comp Pathol. 2013;148(4):373–384.
   PubMed Web of Science ®Google Scholar
• Chen N, Yuan Z-G, Xu M-J, et al. Ascaris suum enolase is a potential vaccine candidate against ascariasis. Vaccine. 2012;30(23):3478–3482.
   PubMed Web of Science ®Google Scholar
• Han K, Xu LF, Yan R, et al. Vaccination of goats with glyceraldehyde-3-phosphate dehydrogenase DNA vaccine induced partial protection against Haemonchus contortus. Vet Immunol Immunopathol. 2012;149(3–4):177–185.
   PubMed Web of Science ®Google Scholar
• Levy S, Shoham T. The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol. 2005;5(2):136–148.
   PubMed Web of Science ®Google Scholar
• Hemler ME. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define anovel type of membrane microdomain. Annu Rev Cell Dev Biol. 2003;19(1):397–422.
   PubMed Web of Science ®Google Scholar
• Piratae S, Tesana S, Jones MK, et al. Molecular characterization of a tetraspanin from the human liver fluke opisthorchis viverrini. PLoS Negl Trop Dis. 2012;6(12):e1939.
   PubMed Web of Science ®Google Scholar
• Tran MH, Freitas TC, Cooper L, et al. Suppression of mRNAs encoding tegument tetraspanins from Schistosoma mansoni results in impaired tegument turnover. PLoS Pathog. 2010;6(4):e1000840.
   PubMed Web of Science ®Google Scholar
• Tran MH, Pearson MS, Bethony JM, et al. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med. 2006;12(7):835–840.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. A phase I study of the safety, reactogenicity, and immunogenicity of Sm-TSP-2/alhydrogel® with or without GLA-AF for intestinal schistosomiasis in healthy adults. Available from: https://clinicaltrials.gov/ct2/show/NCT02337855
   Google Scholar
• Dai Y, Zhu Y, Harn DA, et al. DNA vaccination by electroporation and boosting with recombinant proteins enhances the efficacy of DNA vaccines for Schistosomiasis japonica. Clin Vaccine Immunol. 2009;16(12):1796–1803.
   PubMed Web of Science ®Google Scholar
• Zhu L, Liu H-F, Lu M-B, et al. Construction, purification, and evaluation of multivalent DNA vaccine against Schistosoma japonicum. Parasitol Res. 2011;108(1):115–121.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Fu Z, Zhang M, et al. Protective efficacy evaluation induced by recombinant protein LHD-Sj23-GST of Schistosoma japonicum emulsified with three different adjuvants: protective efficacy evaluation induced by recombinant protein LHD-Sj23-GST of S. japonicum. Parasite Immunol. 2012;34(6):341–344.
   PubMed Web of Science ®Google Scholar
• Yuan W, Qi X, Tsang P, et al. Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules. Proc Natl Acad Sci U S A. 2007;104(13):5551–5556.
   PubMed Web of Science ®Google Scholar
• Espino AM, Hillyer GV. A novel Fasciola hepatica saposinlike recombinant protein with immunoprophylactic potential. J Parasitol. 2004;90(4):876–879.
   PubMed Web of Science ®Google Scholar
• Cardoso FC, Pacifico RNA, Mortara RA, et al. Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies. Clin Exp Immunol. 2006;144(3):382–391.
   PubMed Web of Science ®Google Scholar
• de Assis NRG, de Morais SB, Figueiredo BCP, et al. DNA vaccine encoding the chimeric form of Schistosoma mansoni Sm-TSP2 and Sm29 confers partial protection against challenge infection. PLoS One. 2015;10(5):e0125075.
   PubMed Web of Science ®Google Scholar
• Cardoso FC, Macedo GC, Gava E, et al. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. Plos Neglected Trop Dis. 2008;2(10):e308.
   PubMed Web of Science ®Google Scholar
• Ewaisha RE, Bahey-El-Din M, Mossallam SF, et al. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection. Exp Parasitol. 2014;145(1):51–60.
   PubMed Web of Science ®Google Scholar
• Pinheiro CS, Ribeiro APD, Cardoso FC, et al. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice. Parasite Immunol. 2014;36(7):303–312.
   PubMed Web of Science ®Google Scholar
• McManus DP, Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev. 2008;21(1):225–242.
   PubMed Web of Science ®Google Scholar
• Le L, Zhang W, Karmakar S, et al. Simultaneous priming with DNA encoding Sm-p80 and boosting with Sm-p80 protein confers protection against challenge infection with Schistosoma mansoni in mice. Parasitol Res. 2014;113(3):1195–1200.
   PubMed Web of Science ®Google Scholar
• Ahmad G, Zhang W, Torben W, et al. Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice. Int J Infect Dis. 2010;14(9):e781–e787.
   PubMed Web of Science ®Google Scholar
• Ahmad G, Zhang W, Torben W, et al. Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine. Parasitol Res. 2009;105(6):1767–1777.
   PubMed Web of Science ®Google Scholar
• Karmakar S, Zhang W, Ahmad G, et al. Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons. Vaccine. 2014;32(11):1296.
   PubMed Web of Science ®Google Scholar
• Chen HG, Nara T, Zeng XJ, et al. Vaccination of domestic pig with recombinant paramyosin against Schistosoma japonicum in China. Vaccine. 2000;18(20):2142–2146.
   PubMed Web of Science ®Google Scholar
• Ramirez BL, Kurtis JD, Wiest PM, et al. Paramyosin: a candidate vaccine antigen against Schistosoma japonicum. Parasite Immunol. 1996;18(1):49–52.
   PubMed Web of Science ®Google Scholar
• Matsui M, Fowler JH, Walling LL. Leucine aminopeptidases: diversity in structure and function. Biol Chem. 2006;387(12):1535.
   PubMed Web of Science ®Google Scholar
• Maggioli G, Acosta D, Silveira F, et al. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep. Vaccine. 2011;29(48):9057.
   PubMed Web of Science ®Google Scholar
• Piacenza L, Acosta D, Basmadjian I, et al. Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep. Infect Immun. 1999;67(4):1954–1961.
   PubMed Web of Science ®Google Scholar
• Dalton JP, McGonigle S, Rolph TP, et al. Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin. Infect Immun. 1996;64(12):5066–5074.
   PubMed Web of Science ®Google Scholar
• Golden O, Flynn RJ, Read C, et al. Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1). Vaccine. 2010;28(34):5551–5557.
   PubMed Web of Science ®Google Scholar
• Ricciardi A, Dalton JP, Ndao M. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant. Vaccine. 2015;33(2):346–353.
   PubMed Web of Science ®Google Scholar
• Nebert DW, Vasiliou V. Analysis of the glutathione S-transferase (GST) gene family. Hum Genomics. 2004;1(6):460–464.
   PubMedGoogle Scholar
• Xu C-B, Xu CB, Verwaerde C, et al. A monoclonal antibody blocking the Schistosoma mansoni 28-kDa glutathione S-transferase activity reduces female worm fecundity and egg viability. Eur J Immunol. 1991;21(8):1801–1807.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. Efficacy of vaccine Sh28GST in association with praziquantel (PZQ) for prevention of clinical recurrences of Schistosoma haematobium pathology (Bilhvax). Available from: https://clinicaltrials.gov/ct2/show/NCT00870649.
   Google Scholar
• Wei F, Liu Q, Gao S, et al. Enhancement by IL-18 of the protective effect of a Schistosoma japonicum 26 kDa GST plasmid DNA vaccine in mice. Vaccine. 2008;26(33):4145–4149.
   PubMed Web of Science ®Google Scholar
• Morrison CA, Colin T, Sexton JL, et al. Protection of cattle against Fasciola hepatica infection by vaccination with glutathione S-transferase. Vaccine. 1996;14(17):1603–1612.
   PubMed Web of Science ®Google Scholar
• Boulanger D, Reid GDF, Sturrock RF, et al. Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni. Parasite Immunol. 1991;13(5):473–490.
   PubMed Web of Science ®Google Scholar
• Capron M, Capron A, Riveau G, et al. Schistosomes: the road from host–parasite interactions to vaccines in clinical trials. Trends Parasitol. 2005;21(3):143–149.
   PubMed Web of Science ®Google Scholar
• Riveau G, Deplanque D, Remoué F, et al. Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis. PLoS Negl Trop Dis. 2012;6(7):e1704.
   PubMed Web of Science ®Google Scholar
• Bourke CD, Nausch N, Rujeni N, et al. Cytokine responses to the anti-schistosome vaccine candidate antigen glutathione-S-transferase vary with host age and are boosted by praziquantel treatment. PLoS Negl Trop Dis. 2014;8(5):e2846.
   PubMed Web of Science ®Google Scholar
• Spithill TW, Sexton PMS,JL, Bozas E, et al. The development of vaccines against fasciolosis. In: Dalton JP, editor. Fasciolosis. Oxon: CABI Publishing; 1999. p. 377–410.
   Google Scholar
• Tendler M, Simpson AJG. The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine. Acta Trop. 2008;108(2):263–266.
   PubMed Web of Science ®Google Scholar
• Hillyer GV, Haroun ETM, Hernandez A, et al. Acquired resistance to Fasciola hepatica in cattle using a purified adult worm antigen. Am J Trop Med Hyg. 1987;37(2):363–369.
   PubMed Web of Science ®Google Scholar
• Liu JM, Cai XZ, Lin JJ, et al. Gene cloning, expression and vaccine testing of Schistosoma japonicum SjFABP. Parasite Immunol. 2004;26(89):351–358.
   PubMed Web of Science ®Google Scholar
• Tendler M, Brito CA, Vilar MM, et al. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc Natl Acad Sci U S A. 1996;93(1):269–273.
   PubMed Web of Science ®Google Scholar
• Martínez-Fernández AR, Nogal-Ruiz JJ, López-Abán J, et al. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD. Vet Parasitol. 2004;126(3):287–298.
   PubMed Web of Science ®Google Scholar
• López-Abán J, Casanueva P, Nogal J, et al. Progress in the development of Fasciola hepatica vaccine using recombinant fatty acid binding protein with the adjuvant adaptation system ADAD. Vet Parasitol. 2007;145(3):287–296.
   PubMed Web of Science ®Google Scholar
• Wei F, Liu Q, Liu W, et al. IL-18 enhances protective effect in mice immunized with a Schistosoma japonicum FABP DNA vaccine. Acta Trop. 2009;111(3):284–288.
   PubMed Web of Science ®Google Scholar
• Trelis M, Galiano A, Bolado A, et al. Subcutaneous injection of exosomes reduces symptom severity and mortality induced by Echinostoma caproni infection in BALB/c mice. Int J Parasitol. 2016;46(12):799–808.
   PubMed Web of Science ®Google Scholar
• Palevich N, Britton C, Kamenetzky L, et al. Tackling hypotheticals in helminth genomes. Trends Parasitol. 2017;1471-4922(17):30281–30287.
   Google Scholar
• Egesa M, Hoffmann KF, Hokke CH, et al. Rethinking schistosomiasis vaccine development: synthetic vesicles. Trends Parasitol. 2017;33(12):918–921.
   PubMed Web of Science ®Google Scholar